Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

San Francisco Office Managing Member Stephen Osborn was featured in CoStar discussing Mintz’s upcoming relocation to a 29,000 square foot office on the 30th floor of 525 Market Street in downtown San Francisco. In the article, Steve shared insights into the decision-making process behind the move, emphasizing the importance of selecting a location that clients and employees would want to spend time in.

Mintz Member Rachel Alexander shared insights with Bloomberg Law for an article about how employers are increasingly challenging state laws regulating pharmacy benefit managers (PBM). The piece focuses on the Supreme Court’s recent decision not to review Oklahoma’s Patient’s Right to Pharmacy Choice Act, which the Tenth Circuit had struck down for violating ERISA. While the ruling applies only to the six states under the Tenth Circuit, it may influence similar cases nationwide.

Alexandra Gallo-Cook was quoted by The Deal in an article about a bill that would give New York jurisdiction over a wide array of mergers. If enacted, New York would have the most far-reaching competition law of any state.

Fiduciary News quoted Of Counsel Michelle Capezza in an article about how even though ERISA does not address cybersecurity in its original 1974 text, it requires fiduciaries to act prudently in managing and protecting 401k plans. The DOL issued guidance for 401k plan sponsors in 2021 and 2024, which explicitly ties cybersecurity to fiduciary responsibilities.

San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.

Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.